LOS ANGELES (February 18, 2011) — Scientists at the Children’s Center for Cancer and Blood Diseases and The Saban Research Institute of Children’s Hospital Los Angeles today announced a breakthrough discovery in understanding how the body figh…
A new study published in the journal Clinical Cardiology reveals that a Super Bowl loss for a home team was associated with increased death rates in both men and women and in older individuals.
Sports fans may be emotionally involved in watching th…
LOS ANGELES (December 16, 2010) — Living near a freeway may be associated with increased risk of autism, according to a study published by a team of researchers from Children’s Hospital Los Angeles, the Keck School of Medicine of the Universit…
Approximately 60,000 pregnant women are hospitalized each year due to hyperemesis gravidarum (HG), an extreme form of nausea and vomiting that endangers their lives and often forces them to reluctantly terminate their pregnancies.
And for women…
LOS ANGELES — In research that one day may lead to the discovery of how to regenerate tissue damaged by heart disease, investigators at Childrens Hospital Los Angeles have identified PDGF as a key factor in the proliferation and transformation …
LOS ANGELES (September 7, 2010) — The first study to demonstrate that obesity can directly accelerate the progression of acute lymphoblastic leukemia (ALL) has been conducted at The Saban Research Institute of Childrens Hospital Los Angeles and …
Researchers from the Keck School of Medicine of the University of Southern California, its Doheny Retina Institute and Second Sight, LLC, are reporting on the initial results of their groundbreaking, FDA-approved feasibility trial of an intraocular retinal prosthesis that appears to be able to restore some degree of sight to the blind.
“We have successfully completed enrollment and implantation of three patients in the trial,” says Mark Humayun, M.D., professor of ophthalmology at the Keck School. “And we have found that the devices are indeed electrically conducting, and can be used by the patients to detect light or even to distinguish between objects such as a cup or plate in forced choice tests conducted with one patient so far.”
American children whose genetic roots strongly reach back to Africa are less sensitive to insulin-a factor important in the development of type 2 diabetes-than those whose ancestors hailed heavily from Europe, according to study results released today. Rather than relying on broad categories of race, such as black or white, researchers in diabetes and obesity from the Keck School of Medicine of USC and the University of Alabama at Birmingham analyzed a group of children for 20 key genetic markers found far more often in those of African descent than those of European descent. They found that the more African-origin markers in children’s genetic makeup, the less their bodies responded to insulin-and the more insulin in their blood.
Oral administration of a drug that inhibits a process known as DNA methylation results in a reduction in the size of malignant tumors in mice, according to a team of researchers led by scientists from the Keck School of Medicine of the University of Southern California. The drug, called zebularine, accomplishes its tumor-whittling by turning on tumor suppressor genes that have been turned off by methylation.